frenzy, page-40

re: sirtex goal: $5 then $8 -$9 The new demand in USA from preliminary Nasdaq listing under SXMDF may be fueling some additional demand since in USA biotechs sell for P.E of 20-25 times forward earnings estimates when growing at growth rates of 40-60 %.As Bioshares has conservatve estimate of 72 cents by 2008 this is P.E of 4 and currently growing betwen 90%nd 120% ,the supply of shares is fixed and there is no need to create additional shares and only shares available for active trading are the 8 or 9 million shares in the float.However these shareholders have been very patient over the last 18mos and I feel quite reluctant to give up shares with technicals and fundamentals looking strong. This should result in demand outsripping supply and a quicker mover up over $4+than would normally be anticipated.Also technicians won't have difficult time reading chart as the next resistance is $4.25 -$4.50.My opinion only after being in the industry a while.Do your own work.